Sofiva Genomics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.42	90.61	112.08	96.81	119.81	214.99
Short-Term Investments	34.1	34.1	34.1	43.23	51.15	30.2
Cash & Short-Term Investments	131.52	124.71	146.18	140.03	170.96	245.19
Cash Growth	14.51%	-14.69%	4.39%	-18.09%	-30.27%	11.94%
Accounts Receivable	64.08	62.07	65.94	75.95	75.16	74.04
Other Receivables	13.85	4.45	4.98	9.01	7.53	4.76
Receivables	77.93	66.52	70.92	84.96	82.68	78.8
Inventory	26.26	34.85	46.4	41.79	57.08	41.56
Prepaid Expenses	8.17	8.98	7.95	8.78	10.83	6.58
Other Current Assets	1.04	1.13	1.15	1.79	2.33	1.39
Total Current Assets	244.91	236.2	272.6	277.34	323.88	373.53
Property, Plant & Equipment	56.98	68.92	103.16	116.08	129.23	128.57
Long-Term Investments	400.48	385.39	368.02	348.09	333.32	297.35
Other Intangible Assets	6.7	5.15	8.19	6.86	6.61	6.23
Long-Term Deferred Tax Assets	4.95	5.38	5.06	9.31	6.65	8.91
Other Long-Term Assets	21.6	23.31	11.06	9.45	7.87	7.72
Total Assets	735.62	724.35	768.08	767.14	807.56	822.3
Accounts Payable	17.91	22.64	22.47	31.72	50.6	58.44
Accrued Expenses	-	24.47	33.1	37.15	36.48	30.52
Short-Term Debt	9.69	-	-	-	-	-
Current Portion of Leases	13.3	13.73	16.43	14.43	14.16	14.48
Current Income Taxes Payable	0	0.73	-	-	-	4.22
Current Unearned Revenue	0.84	1.18	1.77	0.77	2.11	2.69
Other Current Liabilities	27.46	8.15	9.68	12.12	12.64	12.99
Total Current Liabilities	69.19	70.9	83.46	96.2	115.99	123.35
Long-Term Leases	15.32	21.8	36.95	49.15	60.52	71.45
Long-Term Deferred Tax Liabilities	0.13	0.14	0.24	0.25	0.62	-
Other Long-Term Liabilities	3.1	3.08	3.03	3.17	3.12	3.06
Total Liabilities	87.74	95.91	123.68	148.77	180.24	197.86
Common Stock	215.93	215.93	215.93	213.62	213.62	213.62
Additional Paid-In Capital	242.63	341.59	341.59	332.06	330.99	328.31
Retained Earnings	90.76	70.82	86.66	72.5	82.34	82.29
Comprehensive Income & Other	98.81	-0.22	-0.15	-0.05	-0.03	0.01
Total Common Equity	648.13	628.13	644.04	618.14	626.92	624.23
Minority Interest	-0.25	0.31	0.36	0.23	0.4	0.21
Shareholders' Equity	647.88	628.43	644.4	618.37	627.32	624.44
Total Liabilities & Equity	735.62	724.35	768.08	767.14	807.56	822.3
Total Debt	38.3	35.53	53.38	63.59	74.67	85.94
Net Cash (Debt)	93.22	89.18	92.8	76.45	96.29	159.26
Net Cash Growth	33.87%	-3.90%	21.39%	-20.61%	-39.54%	35.02%
Net Cash Per Share	4.30	4.13	4.29	3.58	4.50	7.48
Filing Date Shares Outstanding	21.71	21.59	21.59	21.36	21.36	21.36
Total Common Shares Outstanding	21.71	21.59	21.59	21.36	21.36	21.36
Working Capital	175.72	165.3	189.14	181.14	207.89	250.18
Book Value Per Share	29.85	29.09	29.83	28.94	29.35	29.22
Tangible Book Value	641.43	622.98	635.85	611.28	620.3	618
Tangible Book Value Per Share	29.54	28.85	29.45	28.61	29.04	28.93
Machinery	-	144.43	167.48	157.43	144.6	115.73
Leasehold Improvements	-	27.97	28.15	28.33	29.91	29.33